Drug
Arm A Iron Epoietin Zeta
Arm A Iron Epoietin Zeta: highest development phase Post-Market, developed by Vifor Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Vifor Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARM A : IV iron + epoietin zeta NCT02213653 | Post-Market | Solid Cancer Metastatic Disease |
Latest
No recent events.
Follow Arm A Iron Epoietin Zeta on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.